title: Combination of active components of Xiexin decoction ameliorates renal fibrosis through the inhibition of NF-κB and TGF-β1/Smad pathways in db/db diabetic mice.
abstract: Xiexin decoction, a herbal therapeutic agent commonly used in traditional Chinese medicine, is recognized for its beneficial effects on diabetic nephropathy exerted through the combined action of multiple components, including Rhizoma Coptidis alkaloids (A), Radix et Rhizoma Rhei polysaccharides (P), and Radix Scutellaria flavones (F). Our previous studies have shown that a combination of A, P, and F (APF) exhibits renoprotective effects against diabetic nephropathy. This study was aimed at determining the effects of APF on renal fibrosis in diabetic nephropathy and elucidating the underlying molecular mechanisms. To evaluate the effects of APF, in vivo, db/db diabetic mice were orally administered a low or high dose of APF (300 or 600 mg/kg, respectively) once a day for 8 weeks. We evaluated the blood and urine indices of metabolic and renal function, renal tissue histopathology, renal inflammation, and fibrosis. APF treatment significantly ameliorated glucose and lipid metabolism dysfunction, decreased urinary albumin excretion, normalized creatinine clearance, and reduced the morphological changes in renal tissue. Additionally, APF administration in db/db diabetic mice reduced the elevated levels of renal inflammation mediators such as intercellular adhesion molecule-1, monocyte chemotactic protein-1, tumor necrosis factor-α, interleukin-1β, and active nuclear factor κB (NF-κB). APF treatment also reduced type I and IV collagen, transforming growth factor-β1 (TGF-β1), and TGF-β1 type II receptor expression levels, and decreased the phosphorylation of Smad2/3 in the kidneys of db/db diabetic mice. These results suggest that APF reduces renal fibrosis in diabetic nephropathy through the NF-κB and TGF-β1/Smad signaling pathways. In vitro, APF treatment reduced cell proliferation and protein expression of α-smooth muscle actin, collagen I, TGF-β1 and NF-κB in mesangial cells cultured with high glucose concentrations. Our findings indicate that treatment with multi-component herbal therapeutic formulations may be a useful approach for the treatment of diabetic nephropathy.
authors: Department of Pharmacology, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
authors: Jia-Sheng
authors: JS
authors: Wu
authors: Department of Pharmacology, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
authors: Rong
authors: R
authors: Shi
authors: Experiment Center for Science and Technology, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
authors: Xiong
authors: X
authors: Lu
authors: Department of Pharmacology, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
authors: Yue-Ming
authors: YM
authors: Ma
authors: Department of Pharmacology, School of Pharmacy, Fudan University, Shanghai, China.
authors: Neng-Neng
authors: NN
authors: Cheng
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D015153:Blotting, Western; D017931:DNA Primers / Q000235:genetics; D004365:Drugs, Chinese Herbal / Q000737:chemistry* / Q000494:pharmacology*; D005355:Fibrosis; D007150:Immunohistochemistry; D007674:Kidney Diseases / Q000188:drug therapy*; D051379:Mice; D008817:Mice, Mutant Strains; D008854:Microscopy, Electron; D016328:NF-kappa B / Q000037:antagonists & inhibitors*; D060888:Real-Time Polymerase Chain Reaction; D015398:Signal Transduction / Q000187:drug effects*; D051785:Smad Proteins / Q000037:antagonists & inhibitors; D053773:Transforming Growth Factor beta1 / Q000037:antagonists & inhibitors
chemical_list: D017931:DNA Primers; D004365:Drugs, Chinese Herbal; D016328:NF-kappa B; D051785:Smad Proteins; D053773:Transforming Growth Factor beta1; C518364:Xiexin decoction